OCON Therapeutics invented a novel technology that allows for intrauterine drug delivery that could affect the wellbeing of ...

The combination of sacubitril and valsartan reduces the cardiotoxicity related to anthracycline chemotherapy drugs, according ...

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk ...